dexamethasone 21-phosphate has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M; Ito, M; Kataoka, S; Kato, K; Matsumoto, K; Miyagawa, N; Narita, K; Sakaguchi, H; Yoshida, N; Yoshikawa, T | 1 |
1 other study(ies) available for dexamethasone 21-phosphate and Hematologic Malignancies
| Article | Year |
|---|---|
Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy.
Topics: Child; Dexamethasone; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immune System Diseases; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Palmitates; Transplantation, Homologous; Treatment Outcome | 2016 |